NEW YORK (GenomeWeb) – German molecular diagnostics firm GNA Biosolutions said today that it has closed a E6 million ($6.7 million) Series B financing round.

New investor Robert Bosch Venture Capital led the financing. Other new investors include SHS Gesellschaft für Beteiligungsmanagement GmbH, b-to-v Partners, and UnternehemerTUM-Fonds, and join existing shareholders Mey Capital Matrix, KfW, and company founders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.